Indications and uses
• Helps treat and prevent diaper rash • Protects chafed skin due to diaper rash and helps seal out wetness
• Helps treat and prevent diaper rash • Protects chafed skin due to diaper rash and helps seal out wetness
• Shake Well Before Use • Hold bottle 2-3 inches from baby’s bottom while spraying • Press down on the pump to spray • Change wet and solid diapers promptly • Cleanse the diaper area, and allow to dry • Apply spray liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposeure to wet diapers may be prolonged
• Store at 15° to 25°C (59° to 77°F)
Zinc Oxide 10%
Skin Protectant
• Helps treat and prevent diaper rash
• Protects chafed skin due to diaper rash and helps seal out wetness
• For external use only.
• When using this product avoid contact with eyes.
• Condition worsens
• Symptoms last more than seven days or clear up and occur again within a few days.
• Keep this and all drugs out of reach of children. If swallowed, get medical help or
contact a Poison Control Center right away.
• Shake Well Before Use
• Hold bottle 2-3 inches from baby’s bottom while spraying
• Press down on the pump to spray
• Change wet and solid diapers promptly
• Cleanse the diaper area, and allow to dry
• Apply spray liberally as often as necessary, with each diaper change, especially at
bedtime or anytime when exposeure to wet diapers may be prolonged
• Store at 15° to 25°C (59° to 77°F)
*Aqua, *Arachis Hypogaea Oil *C14-22 Alcohol, *C12-20 Alkyl, *Coco-Caprylate/Caprate, *Cocoglycerides,
*Glucoside, *Glycerin, Phenoxyethanol Ethylhexylglycerin, *Oleic Acid and *Silica
*Natural Ingredients
Call toll free 1-800-831-0507
Distributed by: Wake Innovation, LLC
P.O. Box 98355 Raleigh, NC
27624-8355 USA

Nolan’s Diaper Rash Spray
Bum Ease ™
ZINC OXIDE SKIN PROTECTANT DIAPER RASH SPRAY
NEW ZINC OXIDE SPRAY!!
Shake well before using
Patent Pending Spray Formula
• Doctor Recommended
• Fast / Easy Application
• Less Irritation For Baby
• Effective Active Ingredients
• No Greasy Hands or Fingers
3.38 fl. oz. (100 ml.)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1233531 | Bum Ease 10 % Topical Spray | PSN | 3 |
| 1232104 | zinc oxide 10 % Topical Spray | PSN | 3 |
| 1233531 | zinc oxide 100 MG/ML Topical Spray [Bum Ease] | SBD | 3 |
| 1232104 | zinc oxide 100 MG/ML Topical Spray | SCD | 3 |
| 1233531 | Bum Ease 10 % Topical Spray | SY | 3 |
| 1233531 | Bum Ease 100 MG/ML Topical Spray | SY | 3 |
| 1232104 | zinc oxide 10 % Topical Spray | SY | 3 |
| 1232104 | ZNO 100 MG/ML Topical Spray | SY | 3 |
| 1233531 | ZNO 100 MG/ML Topical Spray [Bum Ease] | SY | 3 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76330-100-10 | 2019-11-13 | C162847 | 48780-1 | 97449f38-cd0a-f6ea-e053-dbdaa90aa703 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76330-100-10 | Bum Ease | 1 in 1 BOX | LIQUID | 1 | 3 | |
| 76330-100-10 | Bum Ease | 100 mL in 1 BOTTLE, PUMP | LIQUID | 100 | 3 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 3 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 3 | |
| C12-20 Alkyl Glucoside | INACTIVE INGREDIENT | K67N5Z1RUA | 3 | |
| C14-22 ALCOHOLS | INACTIVE INGREDIENT | B1K89384RJ | 3 | |
| COCO-GLYCERIDES | INACTIVE INGREDIENT | ISE9I7DNUG | 3 | |
| COCONUT ACID | INACTIVE INGREDIENT | 40U37V505D | 3 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 3 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| Oleic Acid | INACTIVE INGREDIENT | 2UMI9U37CP | 3 | |
| PEANUT OIL | INACTIVE INGREDIENT | 5TL50QU0W4 | 3 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 3 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76330-100 | 76330-100-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Zinc Oxide | SOI2LOH54Z | ACTIB |
| Water | 059QF0KO0R | IACT |
| PEANUT OIL | 5TL50QU0W4 | IACT |
| COCONUT ACID | 40U37V505D | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| C14-22 ALCOHOLS | B1K89384RJ | IACT |
| C12-20 Alkyl Glucoside | K67N5Z1RUA | IACT |
| COCO-GLYCERIDES | ISE9I7DNUG | IACT |
| Phenoxyethanol | HIE492ZZ3T | IACT |
| Ethylhexylglycerin | 147D247K3P | IACT |
| Oleic Acid | 2UMI9U37CP | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| PEANUT OIL | PEANUT OIL | 5TL50QU0W4 | SOLUTION / OPHTHALMIC | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| Oleic Acid | OLEIC ACID | 2UMI9U37CP | SOLUTION / TOPICAL | 7.4 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Oleic Acid | OLEIC ACID | 2UMI9U37CP | INJECTION, EMULSION / INTRAVENOUS | 0.03 %w/v | ||
| PEANUT OIL | PEANUT OIL | 5TL50QU0W4 | TABLET / ORAL | NA | ||
| Oleic Acid | OLEIC ACID | 2UMI9U37CP | GEL, METERED / TOPICAL | 88 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| COCONUT ACID | COCONUT ACID | 40U37V505D | SOAP / TOPICAL | 7 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| Oleic Acid | OLEIC ACID | 2UMI9U37CP | CREAM / TOPICAL | 25 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / VAGINAL | 8 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| PEANUT OIL | PEANUT OIL | 5TL50QU0W4 | OIL / TOPICAL | 3000 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| Oleic Acid | OLEIC ACID | 2UMI9U37CP | CAPSULE / ORAL | 8759 mg | ||
| PEANUT OIL | PEANUT OIL | 5TL50QU0W4 | CREAM / TOPICAL | 10 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eef48335-b1b4-431c-8c73-09171d9eba10 | 765a4d0d-a861-4cfc-a87e-bc6b9a35862a | 2011-12-05 | Warnings | eef48335-b1b4-431c-8c73-09171d9eba10 765a4d0d-a861-4cfc-a87e-bc6b9a35862a |
Adverse event summaries are temporarily unavailable. Other product information remains available.